An international prospective cohort study of HIV and Zika in infants and pregnancy (HIV ZIP): study protocol (2021)
- Authors:
- Autor USP: MUSSI, MARISA MARCIA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fgwh.2021.574327
- Subjects: ZIKA VÍRUS; HIV; BEBÊS; GRAVIDEZ
- Keywords: Adverse outcomes; Human immunodeficiency virus; Infants; Pregnancy
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Global Women's Health
- ISSN: 2673-5059
- Volume/Número/Paginação/Ano: v. 2, art. 574327, p. 1-11, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ASCHENGRAU, Ann et al. An international prospective cohort study of HIV and Zika in infants and pregnancy (HIV ZIP): study protocol. Frontiers in Global Women's Health, v. 2, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fgwh.2021.574327. Acesso em: 23 jan. 2026. -
APA
Aschengrau, A., Mussi-Pinhata, M. M., Moye Jr, J., Chakhtoura, N., Patel, K., Williams, P. L., et al. (2021). An international prospective cohort study of HIV and Zika in infants and pregnancy (HIV ZIP): study protocol. Frontiers in Global Women's Health, 2, 1-11. doi:10.3389/fgwh.2021.574327 -
NLM
Aschengrau A, Mussi-Pinhata MM, Moye Jr J, Chakhtoura N, Patel K, Williams PL, Karalius B, Garvie PA, Monte D, Whalen F, Lebov JF, Seage GR. An international prospective cohort study of HIV and Zika in infants and pregnancy (HIV ZIP): study protocol [Internet]. Frontiers in Global Women's Health. 2021 ; 2 1-11.[citado 2026 jan. 23 ] Available from: https://doi.org/10.3389/fgwh.2021.574327 -
Vancouver
Aschengrau A, Mussi-Pinhata MM, Moye Jr J, Chakhtoura N, Patel K, Williams PL, Karalius B, Garvie PA, Monte D, Whalen F, Lebov JF, Seage GR. An international prospective cohort study of HIV and Zika in infants and pregnancy (HIV ZIP): study protocol [Internet]. Frontiers in Global Women's Health. 2021 ; 2 1-11.[citado 2026 jan. 23 ] Available from: https://doi.org/10.3389/fgwh.2021.574327 - Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors
- Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study
- Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants
- Fetal growth assessed via ultrasound in relation to maternal HIV infection status and antiretroviral regimens
- A criança com indícios de infecção congênita: frequência de confirmação diagnóstica e dos diversos agentes envolvidos
- Knowledge and practice of prechewing/ prewarming food by HIV-infectede women
- Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NIDSI perinatal study
- Infecções neonatais hospitalares
- Correlates of neonatal infectious disease morbidity in HIV: uninfected infants born to HIV-infected Latin American and Caribbean Mothers
- Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6–7 months of age: a phase 1/2 randomized trial
Informações sobre o DOI: 10.3389/fgwh.2021.574327 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003235639.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
